Flow-cytometric analysis of DNA distribution after VP16-213 treatment of Lewis lung carcinoma

E. Erba, P. Ubezio, T. Colombo, M. Broggini, L. Torti, M. Vaghi, M. D'Incalci, L. Morasca

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

The two dosage schedules of VP16 that gave the least and the greatest efficacy in Lewis lung carcinoma of the mouse were selected for evaluation of the cytokinetic effects observable in vivo at different intervals after treatment (schedule A: 40 mg/kg IV, on day 8 after transplant; schedule B: 13 mg/kg IV, repeated on days 8, 11 and 14 after transplant). After the single dose and after each repeated dose there was a marked increase in the percentage of cells in the LS-G2-M phases, with a corresponding decrease in the percentage of cells in G0-G1. The number of neoplastic tetraploid cells compared with normal diploid cells in the tumor was reduced after the single IV dose, and more markedly so after repeated doses. This study suggests that the more marked delay of cancer cell growth and greater effectiveness observed with schedule B is related to repeated blockade of the LS-G2-M phases.

Original languageEnglish
Pages (from-to)208-211
Number of pages4
JournalCancer Chemotherapy and Pharmacology
Volume10
Issue number3
DOIs
Publication statusPublished - 1983

Fingerprint

Lewis Lung Carcinoma
Transplants
Appointments and Schedules
G2 Phase
DNA
Cell growth
Cell Division
Tumors
Tetraploidy
Diploidy
Neoplasms
Growth

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Pharmacology

Cite this

Flow-cytometric analysis of DNA distribution after VP16-213 treatment of Lewis lung carcinoma. / Erba, E.; Ubezio, P.; Colombo, T.; Broggini, M.; Torti, L.; Vaghi, M.; D'Incalci, M.; Morasca, L.

In: Cancer Chemotherapy and Pharmacology, Vol. 10, No. 3, 1983, p. 208-211.

Research output: Contribution to journalArticle

@article{1a16616cff9e4e27b333e3106f6d0638,
title = "Flow-cytometric analysis of DNA distribution after VP16-213 treatment of Lewis lung carcinoma",
abstract = "The two dosage schedules of VP16 that gave the least and the greatest efficacy in Lewis lung carcinoma of the mouse were selected for evaluation of the cytokinetic effects observable in vivo at different intervals after treatment (schedule A: 40 mg/kg IV, on day 8 after transplant; schedule B: 13 mg/kg IV, repeated on days 8, 11 and 14 after transplant). After the single dose and after each repeated dose there was a marked increase in the percentage of cells in the LS-G2-M phases, with a corresponding decrease in the percentage of cells in G0-G1. The number of neoplastic tetraploid cells compared with normal diploid cells in the tumor was reduced after the single IV dose, and more markedly so after repeated doses. This study suggests that the more marked delay of cancer cell growth and greater effectiveness observed with schedule B is related to repeated blockade of the LS-G2-M phases.",
author = "E. Erba and P. Ubezio and T. Colombo and M. Broggini and L. Torti and M. Vaghi and M. D'Incalci and L. Morasca",
year = "1983",
doi = "10.1007/BF00255765",
language = "English",
volume = "10",
pages = "208--211",
journal = "Cancer Chemotherapy and Pharmacology",
issn = "0344-5704",
publisher = "Springer Verlag",
number = "3",

}

TY - JOUR

T1 - Flow-cytometric analysis of DNA distribution after VP16-213 treatment of Lewis lung carcinoma

AU - Erba, E.

AU - Ubezio, P.

AU - Colombo, T.

AU - Broggini, M.

AU - Torti, L.

AU - Vaghi, M.

AU - D'Incalci, M.

AU - Morasca, L.

PY - 1983

Y1 - 1983

N2 - The two dosage schedules of VP16 that gave the least and the greatest efficacy in Lewis lung carcinoma of the mouse were selected for evaluation of the cytokinetic effects observable in vivo at different intervals after treatment (schedule A: 40 mg/kg IV, on day 8 after transplant; schedule B: 13 mg/kg IV, repeated on days 8, 11 and 14 after transplant). After the single dose and after each repeated dose there was a marked increase in the percentage of cells in the LS-G2-M phases, with a corresponding decrease in the percentage of cells in G0-G1. The number of neoplastic tetraploid cells compared with normal diploid cells in the tumor was reduced after the single IV dose, and more markedly so after repeated doses. This study suggests that the more marked delay of cancer cell growth and greater effectiveness observed with schedule B is related to repeated blockade of the LS-G2-M phases.

AB - The two dosage schedules of VP16 that gave the least and the greatest efficacy in Lewis lung carcinoma of the mouse were selected for evaluation of the cytokinetic effects observable in vivo at different intervals after treatment (schedule A: 40 mg/kg IV, on day 8 after transplant; schedule B: 13 mg/kg IV, repeated on days 8, 11 and 14 after transplant). After the single dose and after each repeated dose there was a marked increase in the percentage of cells in the LS-G2-M phases, with a corresponding decrease in the percentage of cells in G0-G1. The number of neoplastic tetraploid cells compared with normal diploid cells in the tumor was reduced after the single IV dose, and more markedly so after repeated doses. This study suggests that the more marked delay of cancer cell growth and greater effectiveness observed with schedule B is related to repeated blockade of the LS-G2-M phases.

UR - http://www.scopus.com/inward/record.url?scp=0020572026&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020572026&partnerID=8YFLogxK

U2 - 10.1007/BF00255765

DO - 10.1007/BF00255765

M3 - Article

C2 - 6861265

AN - SCOPUS:0020572026

VL - 10

SP - 208

EP - 211

JO - Cancer Chemotherapy and Pharmacology

JF - Cancer Chemotherapy and Pharmacology

SN - 0344-5704

IS - 3

ER -